Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gal Markel

Showing results (71-80 of 137) with videos related to

Pageof 14
Sort By:
Journal of Surgical Oncology|June 27, 2017
Perioperative BRAF inhibitors in locally advanced stage III melanomaDouglas Zippel, Gal Markel, Roni Shapira-Frommer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2003
Enhanced recognition of human NK receptors after influenza virus infectionHagit Achdout, Tal I Arnon, Gal Markel, et al.
Cancers|August 23, 2020
Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic MelanomaNethanel Asher, Guy Ben-Betzalel, Shaked Lev-Ari, et al.
Anticancer Research|September 15, 2019
Tissue Harvesting for Adoptive Tumor Infiltrating Lymphocyte Therapy in Metastatic MelanomaDouglas Zippel, Orli Friedman-Eldar, Shlomi Rayman, et al.
Oncotarget|December 17, 2017
Histopathological expression analysis of intercellular adhesion molecule 1 (ICAM-1) along development and progression of human melanomaGilli Galore-Haskel, Erez N Baruch, Amy L Berg, et al.
Frontiers in Oncology|June 27, 2022
Trends in Women's Leadership of Oncology Clinical TrialsIthai Waldhorn, Ayelet Dekel, Anna Morozov, et al.
Plos One|March 14, 2013
Development of allogeneic NK cell adoptive transfer therapy in metastatic melanoma patients: in vitro preclinical optimization studiesMichal J Besser, Tsipi Shoham, Orit Harari-Steinberg, et al.
Eye (London, England)|January 23, 2023
Primary cemiplimab treatment for orbital squamous cell carcinoma is effective and may alleviate the need for orbital exenterationAlon Tiosano, Meydan Ben-Ishai, Yaacov Cnaany, et al.
Nature Communications|June 2, 2018
ADAR1-mediated regulation of melanoma invasionYael Nemlich, Erez Nissim Baruch, Michal Judith Besser, et al.
Oncoimmunology|November 20, 2019
Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapySharon Yunger, Assaf Bar El, Li-At Zeltzer, et al.
Pageof 14

Showing results (71-80 of 137) with videos related to

Sort By:
Pageof 14
Journal of Surgical Oncology|June 27, 2017
Perioperative BRAF inhibitors in locally advanced stage III melanomaDouglas Zippel, Gal Markel, Roni Shapira-Frommer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2003
Enhanced recognition of human NK receptors after influenza virus infectionHagit Achdout, Tal I Arnon, Gal Markel, et al.
Cancers|August 23, 2020
Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic MelanomaNethanel Asher, Guy Ben-Betzalel, Shaked Lev-Ari, et al.
Anticancer Research|September 15, 2019
Tissue Harvesting for Adoptive Tumor Infiltrating Lymphocyte Therapy in Metastatic MelanomaDouglas Zippel, Orli Friedman-Eldar, Shlomi Rayman, et al.
Oncotarget|December 17, 2017
Histopathological expression analysis of intercellular adhesion molecule 1 (ICAM-1) along development and progression of human melanomaGilli Galore-Haskel, Erez N Baruch, Amy L Berg, et al.
Frontiers in Oncology|June 27, 2022
Trends in Women's Leadership of Oncology Clinical TrialsIthai Waldhorn, Ayelet Dekel, Anna Morozov, et al.
Plos One|March 14, 2013
Development of allogeneic NK cell adoptive transfer therapy in metastatic melanoma patients: in vitro preclinical optimization studiesMichal J Besser, Tsipi Shoham, Orit Harari-Steinberg, et al.
Eye (London, England)|January 23, 2023
Primary cemiplimab treatment for orbital squamous cell carcinoma is effective and may alleviate the need for orbital exenterationAlon Tiosano, Meydan Ben-Ishai, Yaacov Cnaany, et al.
Nature Communications|June 2, 2018
ADAR1-mediated regulation of melanoma invasionYael Nemlich, Erez Nissim Baruch, Michal Judith Besser, et al.
Oncoimmunology|November 20, 2019
Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapySharon Yunger, Assaf Bar El, Li-At Zeltzer, et al.
Pageof 14